Interruptions of biological and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: a descriptive cohort study assessing trends in patient characteristics in Switzerland

OBJECTIVES: To identify differing patient characteristics at the time of stop and restart of biological or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in rheumatoid arthritis (RA), stratified by stop reason. DESIGN: Explorative descriptive cohort study. SETTING: Swiss Clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Burkard, Theresa, Vallejo-Yagüe, Enriqueta, Hügle, Thomas, Finckh, Axel, Burden, Andrea Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928292/
https://www.ncbi.nlm.nih.gov/pubmed/35292498
http://dx.doi.org/10.1136/bmjopen-2021-056352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928292/
https://www.ncbi.nlm.nih.gov/pubmed/35292498
http://dx.doi.org/10.1136/bmjopen-2021-056352

Ejemplares similares